Further characterization of ADAMTS-13 inactivation by thrombin.

作者: J. K. LAM , C. K. N. K. CHION , S. ZANARDELLI , D. A. LANE , J. T. B. CRAWLEY

DOI: 10.1111/J.1538-7836.2007.02514.X

关键词:

摘要: Summary. Background: The multimeric size and platelettethering function of von Willebrand factor (VWF) are modulated by the plasma metalloprotease, a disintegrin metalloproteinase with thrombospondin type 1 motif, member 13 (ADAMTS-13). In vitro ADAMTS-13 is susceptible to proteolytic inactivation thrombin. Objectives: this study, we aimed characterize ADAMTS13 thrombin assess its physiological significance. Methods results: By N-terminal sequencing cleavage products, mutagenesis, identified principal sites in as R257 R1176. Using library 76 mutants, highlighted functional importance exosite I on proteolysis ADAMTS-13. Proteolysis caused an 8-fold reduction affinity for VWF that contributed loss VWF-cleaving function. Intriguingly, thrombin-cleaved both bound proteolyzed short recombinant A2 domain substrate (VWF115) normally. Following activation coagulation normal plasma, endogenous ADAMTS-13, but not added appeared resistant coagulation-induced fragmentation. An estimation Km was appreciably higher than concentration This corroborated comparatively low (KD 95 nM). Conclusions: Together, our data suggest protected from rapid plasma. Whether remains case under pathological situations involving elevated/sustained generation unclear.

参考文章(30)
D L Higgins, S D Lewis, J A Shafer, Steady state kinetic parameters for the thrombin-catalyzed conversion of human fibrinogen to fibrin. Journal of Biological Chemistry. ,vol. 258, pp. 9276- 9282 ,(1983) , 10.1016/S0021-9258(17)44663-1
N. TURNER, L. NOLASCO, Z. TAO, J.-F. DONG, J. MOAKE, Human endothelial cells synthesize and release ADAMTS-13 Journal of Thrombosis and Haemostasis. ,vol. 4, pp. 1396- 1404 ,(2006) , 10.1111/J.1538-7836.2006.01959.X
Xinglong Zheng, Dominic Chung, Thomas K. Takayama, Elaine M. Majerus, J. Evan Sadler, Kazuo Fujikawa, Structure of von Willebrand Factor-cleaving Protease (ADAMTS13), a Metalloprotease Involved in Thrombotic Thrombocytopenic Purpura Journal of Biological Chemistry. ,vol. 276, pp. 41059- 41063 ,(2001) , 10.1074/JBC.C100515200
J.-J. Wu, K. Fujikawa, B. A. McMullen, D. W. Chung, Characterization of a core binding site for ADAMTS-13 in the A2 domain of von Willebrand factor Proceedings of the National Academy of Sciences of the United States of America. ,vol. 103, pp. 18470- 18474 ,(2006) , 10.1073/PNAS.0609190103
Tomoko Ono, Jun Mimuro, Seiji Madoiwa, Kenji Soejima, Yuji Kashiwakura, Akira Ishiwata, Katsuhiro Takano, Tsukasa Ohmori, Yoichi Sakata, Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure. Blood. ,vol. 107, pp. 528- 534 ,(2006) , 10.1182/BLOOD-2005-03-1087
Zhenyin Tao, Yuandong Peng, Leticia Nolasco, Santiago Cal, Carlos Lopez-Otin, Renhao Li, Joel L. Moake, José A. López, Jing-fei Dong, Recombinant CUB-1 domain polypeptide inhibits the cleavage of ULVWF strings by ADAMTS13 under flow conditions. Blood. ,vol. 106, pp. 4139- 4145 ,(2005) , 10.1182/BLOOD-2005-05-2029
Jing-fei Dong, Joel L. Moake, Aubrey Bernardo, Kazuo Fujikawa, Chalmette Ball, Leticia Nolasco, José A. López, Miguel A. Cruz, ADAMTS-13 Metalloprotease Interacts with the Endothelial Cell-derived Ultra-large von Willebrand Factor Journal of Biological Chemistry. ,vol. 278, pp. 29633- 29639 ,(2003) , 10.1074/JBC.M301385200